Contributed by ReposiTrak Partner Laura Lombard, CEO of ImEPIK Investing in robust training can result in measurable business impact, beyond reducing liability or checking the FDA’s regulatory boxes. The FSMA re...
Contributed by ReposiTrak Partner Laura Lombard, CEO of ImEPIK Investing in robust training can result in measurable business impact, beyond reducing liability or checking the FDA’s regulatory boxes. The FSMA re...